Depressive disorder, major Trials in Oklahoma City, United States
Conditions / Depressive disorder, major / Oklahoma City, United States
Clinical trials for Depressive disorder, major investigate a range of treatment strategies and patient populations.
36 total trials for this combination
Showing top 10 of 36 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05518149 | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) | TERMINATED | — |
| NCT01360866 | Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) | COMPLETED | PHASE3 |
| NCT05518149 | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) | TERMINATED | — |
| NCT03002077 | Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01360632 | Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) | COMPLETED | PHASE3 |
| NCT05550532 | A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy | COMPLETED | PHASE3 |
| NCT00369343 | Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women | COMPLETED | PHASE3 |
| NCT02951988 | A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT00368030 | A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT00406640 | Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women | COMPLETED | PHASE3 |